Net income increased 15.1%
Net income changed +15.1% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed +15.1% from the comparable as-filed period.
Revenue changed +4.5% from the comparable as-filed period.
Gross profit changed +12.1% from the comparable as-filed period.
Cash & equivalents changed -16.9% from the comparable as-filed period.
Debt changed -3.7% from the comparable as-filed period. The change ranks at the 43th percentile of 7 prior comparable changes.
Inventory / revenue changed +59 basis points from the comparable as-filed period.
Research & development changed +7.5% from the comparable as-filed period.
Selling, general & administrative changed +6.5% from the comparable as-filed period.
Inventory changed +6.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
SBC / revenue changed -2 basis points from the comparable as-filed period.
Stock-based compensation changed +0.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.